The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1493
ISSUE1493
April 25, 2016
Maestro Rechargeable System for Weight Loss
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Maestro Rechargeable System for Weight Loss
April 25, 2016 (Issue: 1493)
The FDA has approved the Maestro Rechargeable
System (EnteroMedics), a subcutaneously implanted
device, for use in adults who have not been able to lose
weight with a weight loss program within the past 5 years
and who have a body mass index...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.